Paediatric medicines: applications and procedures
Submitted by Anonymous (not verified) on 8 August 2025 - 9:23
Paediatric medicines: applications and procedures
Key elements form: Applicant’s proposal for a paediatric-investigation-plan opinion
Submitted by Anonymous (not verified) on 8 August 2025 - 9:22
Key elements form: Applicant’s proposal for a paediatric-investigation-plan opinion
3Rs Working Party (3RsWP) plenary meeting - Public session on the 2025-2027 work plan, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 2 April 2025, 09:30 (CEST) to 2 April 2025, 10:30 (CEST)
Submitted by Anonymous (not verified) on 8 August 2025 - 8:37
3Rs Working Party (3RsWP) plenary meeting - Public session on the 2025-2027 work plan, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 2 April 2025, 09:30 (CEST) to 2 April 2025, 10:30 (CEST)
Composition of the Emergency Task Force (ETF) for preparedness
Submitted by Anonymous (not verified) on 7 August 2025 - 15:28
Composition of the Emergency Task Force (ETF) for preparedness
Superseded - Composition of the Emergency Task Force (ETF) for preparedness
Submitted by Anonymous (not verified) on 7 August 2025 - 15:26
Superseded - Composition of the Emergency Task Force (ETF) for preparedness
Applications for new human medicines under evaluation: August 2025
Submitted by Anonymous (not verified) on 7 August 2025 - 13:41
Applications for new human medicines under evaluation: August 2025
Vaccine Monitoring Platform
Submitted by Anonymous (not verified) on 7 August 2025 - 12:47
Vaccine Monitoring Platform
Vaccine Monitoring Platform: List of EMA-funded studies
Submitted by Anonymous (not verified) on 7 August 2025 - 12:45
Vaccine Monitoring Platform: List of EMA-funded studies
Medicine shortage communication (MSC): Zypadhera (olanzapine pamoate monohydrate powder and solvent for prolonged release suspension for injection)
Submitted by Anonymous (not verified) on 7 August 2025 - 10:12
Medicine shortage communication (MSC): Zypadhera (olanzapine pamoate monohydrate powder and solvent for prolonged release suspension for injection)
Agenda - Multi-stakeholder workshop on tailored clinical approach for biosimilars
Submitted by Anonymous (not verified) on 7 August 2025 - 10:08
Agenda - Multi-stakeholder workshop on tailored clinical approach for biosimilars